09:00-09:10

Welcome & Format Review

09:15-10:10

Aligning the “Why” and “How” of Compliance
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

10:15-11:15

Session TBD

11:15-11:30

Break

11:30-12:25

Global Anti-Corruption Enforcement
Wilson Ang,Norton Rose Fulbright (Singapore)
Orlando Vidal, Norton Rose Fulbright (Dubai)

12:30-13:15

Being the Focus of a Government Investigation
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

Optional

Competition Law in Pharmaceutical & Medical Device Sectors with Korea Focus
Hwa-Soo Chung, Kim & Chang (Seoul)

Optional

China Healthcare Compliance Update
Eric Carlson, Covington & Burling LLP (Shanghai)
Ping An, Covington & Burling LLP (Shanghai)

09:00-09:30

Anti-Corruption Settlements
Eric Carlson, Covington & Burling LLP (Shanghai)
Ping An, Covington & Burling LLP (Shanghai)

09:35-10:45

Panel Discussion: Pharma & Device Industry Codes: How Key Interactions are Regulated Under IFPMA, APACMed & Korean Codes; Asia Transparency Trends & Challenges
Hwa-Soo Chung, Kim & Chang (Seoul)
Lucas Nicolet-Serra, Simmons & Simmons LLP (Singapore)

10:50-11:20

COVID-19 Session
Jennifer Oliva, Seton Hall Law School (New Jersey)

11:20-11:35

Break

11:35-12:15

How to Be Recognized as a Trusted Compliance Professional
Young Sang Kwon, Johnson & Johnson (Singapore)

12:20-13:35

Compliance Officers Panel Discussion
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)
Stephanie Chew, Edwards Lifesciences (Shanghai)
Ronald Goon, formerly of Johnson & Johnson (Singapore)
Paul Sumilas, Zimmer Biomet (Singapore)
Moderator: Timothy Glynn, Seton Hall Law School (New Jersey)

13:35-13:45

Case Study Assignments

Optional

Health Care in India: Regulatory Compliance— Prevention is Better Than a Cure
Dr. Milind Antani, Nishith Desai Associates (Mumbai)
Darren Punnen, Nishith Desai Associates (Mumbai)

09:00-09:30

Clinical Trials
Carl Coleman, Seton Hall Law School (New Jersey)

09:35–10:05

Emerging Risk Area—Legal and Compliance Overview of Patient Programs
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

10:05-10:30

Interactive Session on Hot Topics in Patient Programs
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

10:30-10:40

Break

10:40-11:25

Assessing Third-Party Risk
Red Romero, Vifor Pharma Asia Pacific Pte. Ltd. (Singapore)

11:30-12:15

Building an Effective Compliance Program and Team
Stephanie Chew, Edwards Lifesciences (Shanghai)

12:15-12:30

Break

12:30-15:00

Case Study Workshop

09:00-09:30

A Journey to the Dark Side of International Business: Real-World RIsk and Real-World Lessons--Ask Richard
Richard Bistrong, Front-Line Anti-Bribery LLC (Connecticut)

09:35 - 10:15

Data Analytics
Lem Chin Kok, KPMG (Singapore)

10:20-10:45

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations
Ken Chia, Baker & McKenzie, Wong & Leow LLC (Singapore)

10:45-11:00

Break

11:00-12:30

Interactive Session--Part 2: Team Presentations & Classroom Discussion
Ronald Goon Formerly of Johnson & Johnson (Singapore)

12:30-12:45

Closing Remarks/End of Program